This is the eighth article in a review series on Nanomedicine. We started from reviewing the major research and entrepreneurial development of nanomedicine and the relevant patent landscape (Part I and Part II). The first topic we discussed was Organs-on-a-chip (Part III). Following that, we focused on nanotechnology in medical therapeutics. Nanoparticles have nanoscale dimensions and demonstrate unique chemical and physical properties from their bulk. This also gives them great advantages in drug delivery (Part IV), cancer therapeutics (Part V), and bio-imaging (Part VI). In the last installment, we reviewed one special type of nanoparticles: quantum dots, which are incredibly small semiconductor particles (Part VII). Here, we will review the theranostic applications and IP landscape of another special type of nanoparticles known as magnetic nanoparticles (MNP). As in the past, those patent documents cited in the article are summarized in the table at the end.
Magnetic Nanoparticles Magnetic nanoparticles, also known as superparamagnetic nanoparticles are small inorganic crystals about 5-20 nm in diameter. Two main classes of MNPs currently used for clinical imaging are ferromagnetic iron oxide nanoparticles and ultrasmall superparameganetic iron oxide nanoparticles (USPION). MNPs are usually multilayer materials, which give them their various properties and functionalities for diagnosis and disease treatment. The structure of iron oxide nanoparticles has three main components: an iron oxide core as a Magnetic Resonance Imaging (MRI) contrast agent, a biocompatible coating outside the core, and an outer therapeutic coating with specific ligands for biomarker targeting. See (US 8,945,628 by Dr. Ralph Weissleder at Massachusetts General Hospital and US 7,462,446 by Dr. Miqin Zhang at the University of Washington). This unique structure enables MNP accumulation in the sites of interest via biomarker targeting. It further allows the diagnosis of diseases, the evaluation of treatment efficacy, and the localized delivery of drugs and disease therapies. The integration of both diagnostic and therapeutic modalities into one single agent is called a theranostic agent. We will discuss the diagnostic and therapeutic properties of MNPs in cancer.
Magnetic Nanoparticles for Diagnosis In 2008, the International Agency for Research on Cancer reported that the total number of cancer case around the world doubled between 1975 and 2000, and that the number of cases are expected to triple by 2030. This means there will be 13-17 million cancer deaths annually by that time. The only chance for successful treatment of cancer is early cancer diagnosis, by identifying the cancer before the patient shows symptoms. Currently the standard cancer detection technology in the clinic is imaging, such as positron emission tomography (PET) and Magnetic Resonance Imaging (MRI). Dr. Ralph Weissleder at Massachusetts General Hospital (MGH) is a pioneer in the field of clinical imaging using advanced nanomaterials (US 6,615,063, US 8,569,078 and US 9,097,644). He predicted that high resolution molecular imaging technologies (including those utilizing nanoparticles) can screen tumor growth at very early stages.
Currently, there are two main nanoimaging technologies, fluorescence imaging and MRI. In fluorescence imaging, quantum dots can target malignant tissues and show strong localized signals (Part VI). Magnetic nanoparticles demonstrate advanced applications in MRI. MRI is a non-invasive medical imaging technology based on nuclear magnetic resonance. When the magnetic field around the nuclei varies, the nuclei relax their magnetic moment through spin-lattice relaxation and spin-spin relaxation. With the assistance of MRI contrast agents, the MRI captures the change of relaxation times of protons around tissues and forms the medical images. Iron oxide magnetic nanoparticles are one of the currently used contrast agents for MRI. These particles can shorten the spin-lattice relaxation time T1 (brighter signal) and the spin-spin relaxation time T2 (darker signal), forming a sharper and brighter image. These particles can also be actively targeted or passively targeted to malignant sites to differentiate between normal and diseased tissues.
MNPs are the most advanced contrast labels currently being used in research and development for medical imaging. Dr. Shan Wangs group at Stanford University has developed superparameganetic iron oxide nanoparticles (SPIONs) and fluorescent tag conjugated SPIONs for biological molecular imaging (US 7,682,838 and US 8,722,017 ). Dr. Miqin Zhangs group at the University of Washington has developed MNPs with a Fe3O4 core and a mesoporous silica shell embedded with carbon dots and paclitaxel (a common anti-cancer drug), and covered by another layer of silica. These MNPs enable confocal and twophoton fluorescence imaging via carbon dots and MRI via magnetic Fe3O4. They also deliver the paclitaxel to cancer cells to kill them through combined photothermal and chemotherapy. Dr. Zhang also developed major histocompatibility complex (MHC) conjugated MNPs for imaging T cells and also chitosan-polyethylene oxide oligomer copolymer coated MNPs for brain tumor imaging and drug delivery (US 20160193369, US 20150320890, and US 20140286872). Dr. Koichiro Hayashi demonstrated the advantages of using SPIONs for cancer theranostics by combining MRI and magnetic hyperthermia treatment (WO/2012/026194). His team modified the SPION clusters with folic acid and polyethylene glycol (PEG) to promote the accumulation of clusters in tumors. Dr. Qun Zhao at the University of Georgia developed hyperthermia treatment of head and neck cancers in a mouse model via intratumor injection of SPIONs. Ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs) having smaller size in diameter, resulting in longer circulation time. These particles can accumulate in the microvascularture before being endocytosed (i.e. removed) by macrophages. Therefore, these particles can be used for tumor-associated microvessel imaging. Dr. Edward Neuwelt reported clinical data with enhanced brain tumor imaging by USPIONs. Other groups from France and Switzerland also reported similar results.
Summary Magnetic nanoparticles are not only used as MRI contrast labels for medical imaging, but also used as therapeutic drug delivery carriers, as hyperthermia tools, and even as combined drug delivery and imaging agents for cancer therapy. In the next installment, we will discuss further details on the application of these particles in cancer therapeutics.
The General Hospital Corporation
Read the original:
- Is there an alternative to radiation - November 8th, 2009 [November 8th, 2009]
- Taiwan exploring how nanotech affects health - November 8th, 2009 [November 8th, 2009]
- A new way of treating cancer on the way? - November 8th, 2009 [November 8th, 2009]
- Lasers can destroy cancer cells - November 8th, 2009 [November 8th, 2009]
- Fluorescent molecules can be biomarkers - November 8th, 2009 [November 8th, 2009]
- Quick blood tests by using a nanodevice - November 8th, 2009 [November 8th, 2009]
- Where will medicine be 20 years from now - November 8th, 2009 [November 8th, 2009]
- History of nanotechnology - November 8th, 2009 [November 8th, 2009]
- Nanotech and Cancer - November 8th, 2009 [November 8th, 2009]
- Nanotechnology in medicine - November 8th, 2009 [November 8th, 2009]
- How does cancer start - January 25th, 2010 [January 25th, 2010]
- Lung cancer symptoms - January 26th, 2010 [January 26th, 2010]
- Signs of breast cancer - January 27th, 2010 [January 27th, 2010]
- Famous people with cancer - January 29th, 2010 [January 29th, 2010]
- Metastatic renal cancer - January 30th, 2010 [January 30th, 2010]
- What causes skin cancer - January 31st, 2010 [January 31st, 2010]
- How many people die from cancer each year - February 1st, 2010 [February 1st, 2010]
- How much money is spent on cancer research - February 2nd, 2010 [February 2nd, 2010]
- Colon cancer warning signs - February 4th, 2010 [February 4th, 2010]
- Prostate cancer symptoms - February 4th, 2010 [February 4th, 2010]
- Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy - April 25th, 2012 [April 25th, 2012]
- Nano-devices that cross blood-brain barrier open door to treatment of cerebral palsy, other neurologic disorders - April 25th, 2012 [April 25th, 2012]
- Nanomaterial properties in complement activation: lessons from nanomedicine - Video - May 4th, 2012 [May 4th, 2012]
- OMICS Group :: International Conference and Exhibition on Nanotechnology - May 4th, 2012 [May 4th, 2012]
- Use of Nanotechnology in Medicine [FOX 11-27-2011] - Video - May 4th, 2012 [May 4th, 2012]
- Cancer Nanomedicine - Detection - Video - May 4th, 2012 [May 4th, 2012]
- Cancer Nanomedicine - Video - May 4th, 2012 [May 4th, 2012]
- HBIO Reports First Quarter 2012 Revenue Growth of 8% Over First Quarter 2011 - May 5th, 2012 [May 5th, 2012]
- Nano science, focus of Education Ministry - May 7th, 2012 [May 7th, 2012]
- Drug-resistant Bacteria - Designing Nanoparticles For High Antibiotic Doses - May 7th, 2012 [May 7th, 2012]
- Research and Markets: Global Market for Nano Silver - May 10th, 2012 [May 10th, 2012]
- Cracking study makes nanotech breakthrough - May 10th, 2012 [May 10th, 2012]
- Nanoparticles may pose environmental threat - May 16th, 2012 [May 16th, 2012]
- Global Nanobiotechnology Industry - May 17th, 2012 [May 17th, 2012]
- 'Inability to give back Singur land my biggest regret' - May 20th, 2012 [May 20th, 2012]
- 'KOREA PACK 2012' for Packing process industry to be held at KINTEX - May 23rd, 2012 [May 23rd, 2012]
- New ISO Technical Report Guides Characterization of Nanomaterials in Toxicology - May 29th, 2012 [May 29th, 2012]
- DNA strands create tiniest Smileys - May 30th, 2012 [May 30th, 2012]
- Health and fitness agenda: Evolution Asia Yoga Conference - June 2nd, 2012 [June 2nd, 2012]
- UC Davis work in humanities receives $150,000 in UC-wide grants - June 2nd, 2012 [June 2nd, 2012]
- Computer-designed proteins 'may help fight variety of flu viruses' - June 3rd, 2012 [June 3rd, 2012]
- 'Nano technology' [program can pay off big for IRSC students - June 3rd, 2012 [June 3rd, 2012]
- Computer-designed proteins programmed to disarm variety of flu viruses - June 3rd, 2012 [June 3rd, 2012]
- Jugaad innovators don't plan - they improvise - June 6th, 2012 [June 6th, 2012]
- Health and fitness agenda: World Blood Donor Day - June 9th, 2012 [June 9th, 2012]
- OMICS Group :: Journal of Nanomedicine - June 9th, 2012 [June 9th, 2012]
- Researchers develop a 'time bomb' to fight cardiovascular disease - June 10th, 2012 [June 10th, 2012]
- Nanotechnologists develop a 'time bomb' to fight cardiovascular disease - June 10th, 2012 [June 10th, 2012]
- 'Time bomb' to fight cardiovascular disease developed - June 11th, 2012 [June 11th, 2012]
- Asia's First Graphene Nano-Tech Facility Opens In Singapore - June 13th, 2012 [June 13th, 2012]
- How worms are pioneering remote control medicine - June 13th, 2012 [June 13th, 2012]
- Golden Helix Establishes Direct Presence in Japan - June 13th, 2012 [June 13th, 2012]
- STDs Blocked by Nano Gel, Study Suggests - June 15th, 2012 [June 15th, 2012]
- Real Products, Different Results - June 15th, 2012 [June 15th, 2012]
- The Puridone Program - A Breakthrough for Painkiller Addiction - June 15th, 2012 [June 15th, 2012]
- Six startup medical device firms compete in Memphis for fame and fortune - June 19th, 2012 [June 19th, 2012]
- International Nanomedicine Conference bound for Sydney: July 2-4, 2012 - June 19th, 2012 [June 19th, 2012]
- Taming light with graphene - June 21st, 2012 [June 21st, 2012]
- Today on New Scientist: 25 June 2012 - June 26th, 2012 [June 26th, 2012]
- A step towards the future - July 1st, 2012 [July 1st, 2012]
- Genia Technologies Collaborates with Professors Jingyue Ju at Columbia and George Church at Harvard to Develop a ... - October 4th, 2012 [October 4th, 2012]
- Scientists Invited To Submit Proposals For Biological Research In Space - October 4th, 2012 [October 4th, 2012]
- Research and Markets: Micro-Nano Technology XIII from the 13th Annual Conference of Chinese Society of Micro-Nano ... - October 6th, 2012 [October 6th, 2012]
- $80M research facility to open at UMass Lowell - October 6th, 2012 [October 6th, 2012]
- Nano-revolution in drugs delivery - October 8th, 2012 [October 8th, 2012]
- SENAI/SESI of Sao Paulo Selects NanoProfessor as Foundation for "Nanomundo" Nanotechnology Education Initiative - October 8th, 2012 [October 8th, 2012]
- Delivering an integral approach to emotional and mental health - October 9th, 2012 [October 9th, 2012]
- NanoGuardian's On-Dose NanoEncryption Brand Protection Technology to Be Presented at AAPS Annual Meeting - October 11th, 2012 [October 11th, 2012]
- Il Nano Mondo del professor Ennio Tasciotti - Video - October 30th, 2012 [October 30th, 2012]
- Deakin University - Practical Science - Nano medicine - Video - October 30th, 2012 [October 30th, 2012]
- 2012 Deakin University 3 Minute Thesis Finalist - Jarrad Altimari - Video - October 30th, 2012 [October 30th, 2012]
- Nano Medicine from "Development of Nanotechnology in Hong Kong" - Video - October 30th, 2012 [October 30th, 2012]
- NANO Medicine 1 3 xvid - Video - October 30th, 2012 [October 30th, 2012]
- Nanolääke // Nano medicine - Video - October 30th, 2012 [October 30th, 2012]
- NANO Medicine (1-3) - Video - October 30th, 2012 [October 30th, 2012]
- Jefferson County, Colorado's Bioscience Industry - Video - October 30th, 2012 [October 30th, 2012]
- NanoMission - Nanomedicine NanoBot - Video - October 30th, 2012 [October 30th, 2012]
- Study aims to unlock mysteries of autism - November 20th, 2012 [November 20th, 2012]
- Catherine Griwkowsky - November 22nd, 2012 [November 22nd, 2012]
- Kulkarni to be feted at Bangalore Nano 2012 - November 26th, 2012 [November 26th, 2012]